USPTO serial 88118686
DIGITOME
Reviewed by CopyMark Law Group
Reg. 6010838Status 710
- Filing date
- Status date
- Registration date
- Mar 17, 2020
- Examiner
- MURRAY, DAVID T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DIGITOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Palo Alto, CA, US
Palo Alto, CA, US
Palo Alto, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Omar M. Wadhwa
Omar M. Wadhwa Cesari and McKenna, LLPOne Liberty SquareBoston, MA 02109UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SAAS) services, namely, hosting software for use by others for use for disease progression prediction; Software as a service (SAAS) services, namely, hosting software for use by others for use for medical status assessment; Software as a service (SAAS) services, namely, hosting software for use by others for use for overall health assessment; Software as a service (SAAS) services, namely, hosting software for use by others for use to determine effective therapies and medications; Software as a service (SAAS) services, namely, hosting software for use by others for use to make medical decisions; Application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of human health and disease data; Application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of genetic data; Application service provider (ASP) featuring software for use to derive insights and or understanding about human health and disease.; Application service provider (ASP) featuring software for use for predictive analytics; Application service provider (ASP) featuring software for use for disease progression prediction; Application service provider (ASP) featuring software for use for medical status assessment; Application service provider (ASP) featuring software for use for overall health assessment; Application service provider (ASP) featuring software for use to determine effective therapies and medications; Application service provider (ASP) featuring software for use to make medical decisions; Application service provider (ASP) featuring software for use to assist in overall medical and therapeutic decision making; Conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Medical and scientific research, namely, conducting clinical trials for others; Platform as a service (PAAS) featuring computer software platforms for in the collection, processing, storage and exchange of human health and disease data; Platform as a service (PAAS) featuring computer software platforms for in the collection, processing, storage and exchange of genetic data; Platform as a service (PAAS) featuring computer software platforms for to derive insights and or understanding about human health and disease.; Platform as a service (PAAS) featuring computer software platforms for for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for for medical status assessment; Platform as a service (PAAS) featuring computer software platforms for for overall health assessment; Platform as a service (PAAS) featuring computer software platforms for to determine effective therapies and medications; Platform as a service (PAAS) featuring computer software platforms for to make medical decisions; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials | SECTION 8 - CANCELLED | Oct 11, 2017 |
| 044 | Health care services, namely, providing a database in the field of disease detection and management information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of disease therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes | SECTION 8 - CANCELLED | Oct 11, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 17, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 31, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 31, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 11, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 4, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 4, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 26, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 26, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 26, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 26, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 26, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 6, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Sep 30, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Sep 30, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 30, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 30, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 1, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 1, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 19, 2018 | NWAP | NEW APPLICATION ENTERED | — |